tiprankstipranks
Apellis Pharmaceuticals Inc (APLS)
NASDAQ:APLS

Apellis Pharmaceuticals (APLS) Similar Stocks

Compare
882 Followers

Comparison Results

Name
Price
Market Cap
P/E Ratio
Yearly Gain
Analyst Consensus
Analyst Price Target
Top Analysts' Price Target
Smart Score
Follow
Apellis Pharmaceuticals
$23.79
$2.98B
-59.68%
12 Buy
8 Hold
0 Sell
Moderate Buy
Alnylam Pharma
$269.21
$36.55B
77.15%
18 Buy
4 Hold
0 Sell
Strong Buy
Neurocrine
$114.45
$11.58B
35.30
-18.92%
17 Buy
5 Hold
0 Sell
Strong Buy
Regeneron
$640.14
$69.33B
17.24
-33.48%
16 Buy
3 Hold
1 Sell
Strong Buy
Vertex Pharmaceuticals
$500.28
$130.72B
19.88%
15 Buy
10 Hold
1 Sell
Moderate Buy
Sarepta Therapeutics
$72.88
$7.41B
30.88
-43.17%
17 Buy
2 Hold
1 Sell
Strong Buy

Performance Comparison

Ticker
Company Name
Price
Change
% Change
APLS
Apellis Pharmaceuticals
23.79
-34.70
-59.33%
ALNY
Alnylam Pharma
269.21
114.82
74.37%
NBIX
Neurocrine
114.45
-23.38
-16.96%
REGN
Regeneron
640.14
-324.92
-33.67%
VRTX
Vertex Pharmaceuticals
500.28
82.96
19.88%
SRPT
Sarepta Therapeutics
72.88
-57.35
-44.04%
Compare key indicators and discover each stock’s average analyst price target, as well as the latest recommendations by top Wall Street experts
What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis